胸部肿瘤内科治疗策略.pptVIP

  • 3
  • 0
  • 约1.62万字
  • 约 83页
  • 2018-12-30 发布于浙江
  • 举报
* * 本页要点:EGFR-TKI药物用于二线治疗,对于EGFR突变阴性的疗效要远远差于突变阳性的患者,有的有效率只有2.6。因此,在TKI药物应用于二线治疗时也要进行EGFR突变的检测,才能保证患者的获益 * Metastatic (extensive-stage) disease is present at diagnosis in most patients with SCLC. Thus, survival is usually not affected by small changes in the amount of locoregional tumour involvement, as it is for NSCLC. Thus, although relevant, the detailed TNM staging previously described (which is more appropriate when surgery is being considered) is not commonly employed for staging SCLC. Instead, a simplified staging system of ‘limited’ versus ‘extensive’ disease is used.1 Approximatel

文档评论(0)

1亿VIP精品文档

相关文档